Dr. Drew Pinsky praised Thursday’s announcement of a Trump-brokered deal to expand Medicare coverage for popular weight-loss drugs but warned on Newsmax that the medications, known as GLP-1 (Glucagon-Like Peptide-1) inhibitors, are not without serious risks.
Appearing on “Finnerty” with host Rob Finnerty, the physician and media personality said that while the decision could be life-changing for millions of Americans battling obesity, it will also carry major financial and medical implications.
“So Medicare will cover it now was really the main thing,” Pinsky said.
Read more at Newsmax© 2025 Newsmax. All rights reserved.
